Kevin T Conroy Exact Sciences Corp (EXAS) insider trading activity

EXAS Quotes by TradingView

Kevin T Conroy is President and CEO of EXACT SCIENCES CORP. Currently has a direct ownership of 1.11 Million shares of EXAS, which is worth approximately $54.6 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 21,140 shares (Common Stock) at a price of $50.48 per share, resulting in proceeds of $1,067,147. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.11M
3.17% 3M change
13.6% 12M change
Total Value Held $54.6 Million

Kevin T Conroy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
SELL
Payment of exercise price or tax liability
$1,067,147 $50.48 p/Share
21,140 Reduced 1.87%
1,108,198 Common Stock
Feb 20 2025
BUY
Grant, award, or other acquisition
-
48,044 Added 4.08%
1,129,338 Common Stock
Feb 19 2025
SELL
Payment of exercise price or tax liability
$162,339 $49.63 p/Share
3,271 Reduced 0.3%
1,081,294 Common Stock
Feb 19 2025
BUY
Exercise of conversion of derivative security
-
10,374 Added 0.95%
1,084,565 Common Stock
Nov 13 2024
BUY
Open market or private purchase
$1,001,325 $51.35 p/Share
19,500 Added 1.78%
1,074,191 Common Stock
May 01 2024
SELL
Open market or private sale
$69,473 $60.15 p/Share
1,155 Reduced 0.1%
1,156,191 Common Stock
Apr 30 2024
BUY
Grant, award, or other acquisition
$47,986 $15.01 p/Share
3,197 Added 0.28%
1,157,346 Common Stock
Mar 01 2024
SELL
Open market or private sale
$490,635 $59.32 p/Share
8,271 Reduced 0.63%
1,299,496 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
-
18,143 Added 1.37%
1,307,767 Common Stock
Feb 27 2024
SELL
Open market or private sale
$356,302 $56.89 p/Share
6,263 Reduced 0.48%
1,289,624 Common Stock
Feb 26 2024
BUY
Exercise of conversion of derivative security
-
13,181 Added 1.01%
1,295,887 Common Stock
Feb 23 2024
SELL
Payment of exercise price or tax liability
$3,541,546 $57.53 p/Share
61,560 Reduced 4.58%
1,282,706 Common Stock
Feb 23 2024
BUY
Exercise of conversion of derivative security
$1,435,604 $13.96 p/Share
102,837 Added 7.11%
1,344,266 Common Stock
Feb 22 2024
SELL
Open market or private sale
$691,355 $59.78 p/Share
11,565 Reduced 0.92%
1,241,429 Common Stock
Feb 21 2024
SELL
Open market or private sale
$305,962 $61.5 p/Share
4,975 Reduced 0.4%
1,229,756 Common Stock
Feb 21 2024
BUY
Grant, award, or other acquisition
-
23,238 Added 1.82%
1,252,994 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
-
10,374 Added 0.83%
1,234,731 Common Stock
Feb 15 2024
SELL
Open market or private sale
$908,611 $61.43 p/Share
14,791 Reduced 1.19%
1,224,357 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
-
31,133 Added 2.45%
1,239,148 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
$21,284 $30.02 p/Share
709 Added 0.06%
1,208,015 Common Stock
Feb 28 2023
SELL
Open market or private sale
$636,625 $61.12 p/Share
10,416 Reduced 0.86%
1,207,306 Common Stock
Feb 27 2023
BUY
Exercise of conversion of derivative security
-
22,492 Added 1.81%
1,217,722 Common Stock
Feb 22 2023
SELL
Open market or private sale
$298,798 $62.72 p/Share
4,764 Reduced 0.4%
1,195,230 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
10,374 Added 0.86%
1,199,994 Common Stock
Feb 15 2023
SELL
Open market or private sale
$958,729 $65.59 p/Share
14,617 Reduced 1.21%
1,189,620 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
Director
ADPT
Adaptive Biotechnologies Corp Healthcare
Director
SLGC
SomaLogic, Inc. Healthcare
Director
ALGN
ALIGN TECHNOLOGY INC Healthcare
KTC

Kevin T Conroy

President and CEO
Madison, WI

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EXAS